Showing results (101-110 of 259) with videos related to
Sort By:
Pageof 26
Journal of Neuroinflammation|April 30, 2020
Novel alterations in corneal neuroimmune phenotypes in mice with central nervous system tauopathyHaihan Jiao, Laura E Downie, Xin Huang, et al.Frontiers in Oncology|July 28, 2022
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma TreatmentXiaoshuang Hou, Sui Chen, Po Zhang, et al.Journal of Biomedicine & Biotechnology|December 17, 2009
Production of polyclonal antibody against interleukin-33 and assessment of its distribution in murine liver and lungXiaojin Liu, Yan Wu, Mingcai Li, et al.Journal of Ethnopharmacology|September 26, 2009
Mutagenic and antimutagenic activities of aqueous and methanol extracts of Euphorbia hirtaDaphne Sue Yen Loh, Hui Meng Er, Yu Sui ChenNeuropharmacology|April 15, 2005
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptorsDavide Cervia, Daniel Langenegger, Edi Schuepbach, et al.Chimia|December 2, 2014
SOM230: a new therapeutic modality for Cushing's diseaseIan Lewis, Herbert A Schmid, Rainer Kneuer, et al.Biological Psychiatry|December 25, 2007
The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learningStephanie Bissière, Nicolas Plachta, Daniel Hoyer, et al.Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonistsThomas Troxler, Daniel Hoyer, Daniel Langenegger, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptorsCaroline Nunn, Magnus Rueping, Daniel Langenegger, et al.Brain Research|October 1, 2008
Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNAYann Senechal, Laetitia Prut, Peter H Kelly, et al.Pageof 26